Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances

Pathobiology

Volumn 79, Issue 3, 2012, Pages 115-126

  Wilkens, Ludwig ^a,b   Hammer, Caroline ^a   Glombitza, Sabine ^b   Müller, Dominique Elisabeth ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Klinikum Region Hannover   (Switzerland)

Author keywords

Array CGH; Cell lines; Cholangiocellular carcinoma; Chromosomal aberrations; Cytogenetics; Hepatocellular carcinoma

Indexed keywords

ANEUPLOIDY; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 1; CHROMOSOME 11P; CHROMOSOME 12P; CHROMOSOME 13; CHROMOSOME 14Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17; CHROMOSOME 1Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 8; CHROMOSOME DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PLOIDY; PRIORITY JOURNAL;

ADENOMA, BILE DUCT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS;

EID: 84855889902     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000334100     Document Type: Article

References (24)

1. Schirmacher P, Dienes HP: Hepatocellular carcinoma; in Kurzrock R, Talpaz M, (eds): Molecular Biology in Cancer Medicine. London, Dunitz, 1999, pp 355-366.
2. El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35: 72-78.
3. Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, Wang XW: Distinctive gene expression profiles associated with hepatitis B virus x protein. Oncogene 2001; 20: 3674-3682. (Pubitemid 32624959)
4. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG: Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003; 63: 859-864. (Pubitemid 36231988)
5. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61: 2129-2137. (Pubitemid 32692038)
6. Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Takashima M, Sakamoto K, Tangoku A, Miyamoto T, Uchimura S, Hamamoto Y: Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol 2004; 24: 565-574.
7. Neo SY, Leow CK, Vega VB, Long PM, Islam AF, Lai PB, Liu ET, Ren EC: Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 2004; 39: 944-953. (Pubitemid 38428933)
8. Miller G, Socci ND, Dhall D, D'Angelica M, DeMatteo RP, Allen PJ, Singh B, Fong Y, Blumgart LH, Klimstra DS, Jarnagin WR: Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract. J Exp Clin Cancer Res 2009; 28: 62.
9. Randi G, Franceschi S, La Vecchia C: Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602. (Pubitemid 43376420)
10. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-1281.
11. Hertz S, Rothamel T, Giere C, Skawran B, Steinemann D, Flemming A, Becker T, Flik J, Wiese B, Kreipe H, Schlegelberger B, Wilkens L: Losses of chromosome arms 4q and 13q are correlated with increasing chromosomal instability and gains of 8q with increasing polyploidy in hepatocellular carcinoma. Pathobiology 2008; 75: 312-322.
12. Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P: Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade - results of an explorative CGH meta-analysis. Br J Cancer 2005; 92: 935-941. (Pubitemid 40462642)
13. Liguori MJ, Anderson MG, Bukofzer S, Mc- Kim J, Pregenzer JF, Retief J, Spear BB, Waring JF: Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology 2005; 41: 177-186. (Pubitemid 40066396)
14. Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, Chen C, Liu SQ, Wu MC, Wang HY: Wnt/ beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 2008; 68: 4287-4295.
15. Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L: Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin Gastro Hepatol 2006; 4: 1283-1291. (Pubitemid 44512219)
16. Skawran B, Steinemann D, Becker T, Buurman R, Flik J, Wiese B, Flemming P, Kreipe H, Schlegelberger B, Wilkens L: Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma. Mod Pathol 2008; 21: 1479-1489.
17. Hertz S, Rothamel T, Giere C, Skawran B, Steinemann D, Flemming A, Becker T, Flik J, Wiese B, Kreipe H, Schlegelberger B, Wilkens L: Losses of chromosome arms 4q and 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma. Pathobiology 2008; 75: 312-322.
18. Dessen P, Knuutila S, Huret JL: Chromosome 13. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2004. http:// AtlasGeneticsOncology. org/Indexbychrom/ idxa-13.
19. Homayounfar K, Gunawan B, Cameron S, Haller F, Baumhoer D, Uecker S, Sander B, Ramadori G, Lorf T, Fuzesi L: Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization. Hum Pathol 2009; 40: 834-842.
20. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes Chromosomes Cancer 1994; 10: 221-230. (Pubitemid 24238429)
21. Carvalho CM, Lupski JR: Copy number variation at the breakpoint region of isochromosome 17q. Genome Res 2008; 18: 1724-1732.
22. Dessen P, Knuutila S, Huret JL: Atlas of Genetics and Cytogenetics in Oncology and Haematology, Chromosome 12. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2004. http:// AtlasGeneticsOncology.org/Indexbychrom/ idxa-12.
23. Hwang ES, Nyante SJ, Yi CY, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM: Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562-2572. (Pubitemid 38715760)
24. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM: Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 2009; 33: 1683-1694.